Event Description

Name: Why Physicians Are Optimistic about Newly Diagnosed Myeloma
Start: 2021-02-18T11:00:00-07:00
End: 2021-02-18T12:00:00-07:00

Fear, uncertainty, and pessimism accompany virtually every cancer diagnosis, especially if most patients, like those with myeloma, have never even heard the word before. Yet myeloma specialists are increasingly confident and optimistic that the vast majority of diagnosed patients have legitimate paths toward longevity, good quality of life, and will benefit from increasing treatment options and experience. Join us as we review the Myeloma Crowd Round Table featuring Multiple Myeloma Specialists. After we review the MCRT, Dr. Sarah Lee will serve as our moderator for a Q&A. Come with questions! This is a Google Meet Meeting. You can join even if you don't have a Gmail Account. If you are joining via mobile, please make sure you have the Google Meet App downloaded.

Schedule & Agenda

Introductions

11:00AM

Audrey Burton-Bethke

Audrey Burton-Bethke, Manager of the Myeloma Community, introduces the agenda of the event and Dr. Sarah Lee who will moderate our Q&A.

11:00AM

Audrey Burton-Bethke

Introductions

Audrey Burton-Bethke, Manager of the Myeloma Community, introduces the agenda of the event and Dr. Sarah Lee who will moderate our Q&A.

Presentation: Why Physicians are Optimistic about Newly Diagnosed Myeloma

11:05AM

Myeloma Crowd Round Table

Watch portions of the Myeloma Crowd Round Table session and hear from multiple myeloma specialists about why they are optimistic about newly diagnosed myeloma.

11:05AM

Myeloma Crowd Round Table

Presentation: Why Physicians are Optimistic about Newly Diagnosed Myeloma

Watch portions of the Myeloma Crowd Round Table session and hear from multiple myeloma specialists about why they are optimistic about newly diagnosed myeloma.

Questions and Answers

11:35AM

Sarah Lee, MD

Dr. Sarah Lee will moderate our Q&A. What questions did the MCRT spark for you? What other questions do you have?

11:35AM

Sarah Lee, MD

Questions and Answers

Dr. Sarah Lee will moderate our Q&A. What questions did the MCRT spark for you? What other questions do you have?

Speakers & Moderators

Audrey Burton-Bethke

Audrey joined the Myeloma Crowd as the Community Manager in 2020 after previously working in the nonprofit field for 4 years as a director of Fundraising and Development. She graduated from BYU with a major in Spanish and Nonprofit Management. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio

Sarah Lee, MD

Dr. Lee is a hematologist-oncologist who specializes in the care of patients with plasma cell disorders. Before joining SCCA, she completed a fellowship in hematology-oncology at the Cleveland Clinic. Her background also includes experience in researching novel therapies for multiple myeloma, amyloidosis, and other plasma cell disorders. What drew her to SCCA was the opportunity to participate in clinical research and to embrace a collaborative approach to medicine.

Read Bio